It suggests that mRNA of ENG and LEP have potential to be circulating biomarkers for diagnosis and therapeutic target in most instances of early and/or late onset placental insufficiency IUGR characteristic of the above clinical signs. This evidence concerns the gene LEP and placental insufficiency.